Drug Shortage Report for TARO-RIVAROXABAN
Report ID | 222101 |
Drug Identification Number | 02483823 |
Brand name | TARO-RIVAROXABAN |
Common or Proper name | Rivaroxaban |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | RIVAROXABAN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | B01AF |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-05 |
Estimated end date | 2024-03-22 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-13 | French | Compare |
v1 | 2024-03-13 | English | Compare |
Showing 1 to 2 of 2